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ischemic stroke. Prior clinical research has focused on the efﬁcacy and safety of carotid revascularization, but few
investigators have considered readmission as a clinically important outcome.
OBJECTIVES The aims of this study were to examine frequency, timing, and diagnoses of 30-day readmission following
carotid revascularization; to assess differences in 30-day readmission between patients undergoing carotid endarterectomy
(CEA) and carotid artery stenting (CAS); to describe hospital variation in risk-standardized readmission rates (RSRR); and to
examine whether hospital variation in the choice of procedure (CEA vs. CAS) is associated with differences in RSRRs.
METHODS We used Medicare fee-for-service administrative claims data to identify acute care hospitalizations for CEA
and CAS from 2009 to 2011. We calculated crude 30-day all-cause hospital readmissions following carotid revasculari-
zation. To assess differences in readmission after CAS compared with CEA, we used Kaplan-Meier survival curves and
ﬁtted mixed-effects logistic regression. We estimated hospital RSRRs using hierarchical generalized logistic regression.
We stratiﬁed hospitals into 5 groups by their proportional CAS use and compared hospital group median RSRRs.
RESULTS Of 180,059 revascularizations from 2,287 hospitals, CEA and CAS were performed in 81.5% and 18.5% of
cases, respectively. The unadjusted 30-day readmission rate following carotid revascularization was 9.6%. Readmission
risk after CAS was greater than that after CEA. There was modest hospital-level variation in 30-day RSRRs (median: 9.5%;
range 7.5% to 12.5%). Variation in proportional use of CAS was not associated with differences in hospital RSRR (range of
median RSRR across hospital groups 9.49% to 9.55%; p ¼ 0.771).
CONCLUSIONS Almost 10% of Medicare patients undergoing carotid revascularization were readmitted within 30 days
of discharge. Compared with CEA, CAS was associated with a greater readmission risk. However, hospitals’ RSRR did not
differ by their proportional CAS use. (J Am Coll Cardiol 2015;65:1398–408) © 2015 by the American College of
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AB BR E V I A T I O N S
AND ACRONYM S
CAS = carotid artery stenting
CC = condition category
CEA = carotid endarterectomy
CMS = Centers for Medicare &
Medicaid Services
ICD-9-CM = International
Classiﬁcation of Diseases-Ninth
Revision-Clinical Modiﬁcation
RSRR = risk-standardized
ission rate
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1399readmissions following carotid revascularization has
increased dramatically with the development of a
measure of hospitals’ 30-day risk-standardized read-
mission rates (RSRRs) following vascular procedures
(3), with implications for potential ﬁnancial penalties
for hospitals with excess readmissions.
At present, many aspects of readmissions following
carotid revascularization are poorly understood.
Speciﬁcally, the timing and reasons for readmission,
as well as the extent of variation in hospitals’ 30-day
readmission rates, have not been described. Fur-
thermore, like many vascular procedures, carotid
revascularization can be accomplished through an
open or endovascular approach (carotid endarterec-
tomy [CEA] and carotid artery stenting [CAS],
respectively). Although prior research has shown that
patients undergoing CAS are at increased risk for
readmission compared with patients undergoing CEA
(2), it is not known whether differences in hospitals’
proportional use of CAS among all carotid revascu-
larization procedures are associated with differences
in hospital 30-day readmission rates.SEE PAGE 1409To address these gaps in knowledge, we used
administrative claims data to identify readmissions
occurring within 30 days of the end of hospitalization
during which a carotid revascularization procedure
was performed. We examined the timing and di-
agnoses associated with readmission and character-
ized variation in RSRRs across hospitals. Furthermore,
we assessed whether readmission rates varied by the
choice of the revascularization strategy used (CAS vs.
CEA) and whether hospitals’ 30-day RSRRs differed
by the proportional use of CAS among all carotid
revascularization procedures.
METHODS
We used Medicare fee-for-service administrative
claims data to identify hospitalizations with an asso-
ciated carotid revascularization procedure performed
between January 1, 2009 and December 31, 2011. We
identiﬁed patients using International Classiﬁcation
of Diseases-Ninth Revision-Clinical Modiﬁcation
(ICD-9-CM) codes or Current Procedural Terminology
codes, previously reported by the Centers for Medi-
care & Medicaid Services (CMS) vascular procedure
readmission measure (3). As with this measure, our
study sample consisted of patients who underwent
either CEA (ICD-9-CM codes 00.61, 00.63, 00.64,
39.72, 39.74; Current Procedural Terminology codes
37215, 37216, 0075T) or CAS (ICD-9-CM codes 38.02,
38.12, 38.32, 38.42 or Current Procedural Terminologycodes 35201, 35005, 35231, 35301, 35701,
34001). Whether patients were symptomatic
(i.e., had symptoms attributable to their ca-
rotid disease) was determined using the
following ICD-9-CM codes previously
described in published reports (2,4,5): 362.30,
362.31, 362.32, 362.33, 362.34, 362.35, 362.36,
362.37, 362.84, 433.11, 433.31, 434.01, 434.91,
435.0, 435.1, 435.2, 435.3, 435.8, 435.9, and
781.4. The primary outcome of interest was
hospital readmission within 30 days of
discharge from a hospitalization during
which a carotid revascularization procedure had been
performed. Among patients who had been read-
mitted, we examined the timing of the readmission
by day after discharge (0 to 30). We categorized
readmission diagnoses using the CMS condition
category (CC) codes to group patients’ principal
discharge diagnoses. Each of the 189 CMS CCs de-
scribes a disease entity or medical condition. How-
ever, because more than 90% of these CCs
contributed <1% of all readmissions, we further
consolidated the 189 CMS CCs into 30 modiﬁed CCs.
The categorization of CCs is described in Online
Tables 1 and 2.
STATISTICAL ANALYSES. We used descriptive
statistics to illustrate baseline characteristics. We
compared differences in baseline characteristics
between CEA and CAS patients using the Mantel-
Haenszel chi-square test and the Student t test, as
appropriate. We calculated crude readmission rates
following carotid revascularization procedures by
dividing the number of patients readmitted within
the 30-day period following carotid revascularization
by the total number of patients undergoing carotid
revascularization. To examine the timing of read-
mission following carotid revascularization, we
calculated the proportion of readmissions during
each day over the 30-day period. We also identiﬁed
the 10 most common diagnoses associated with
readmission by modiﬁed CCs and presented their
distribution over the following consecutive time pe-
riods after hospital discharge: days 0 to 7, 8 to 15, and
16 to 30, reﬂecting the time periods in which follow-
up visits to ambulatory care providers frequently
occur.
PROCEDURE-SPECIFIC READMISSION RATES: CAS
VERSUS CEA. To assess the difference in readmission
rates between patients undergoing CEA versus CAS,
we plotted Kaplan-Meier readmission-free survival
curves and ﬁtted a generalized estimating equation
logistic regression model. These models adjusted for
patient and hospital characteristics. In these models,
readm
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ﬁxed effects except the hospital variable, which was
considered as a random effect to account for within-
hospital correlation.
To account for baseline differences between CEA
and CAS, we used propensity score matching to create
a new matched dataset (N ¼ 64,238) on the basis
of age, sex, race, symptomatic status, and other
comorbidities identiﬁed in the multivariable model.
After matching, the standardized difference in any
variable between the 2 groups did not exceed 10%
(Online Table 3), indicating successful matching with
respect to the chosen matching variables. We then ﬁt
a generalized estimating equation model using this
propensity-matched cohort.
HOSPITAL-SPECIFIC RISK-STANDARDIZED READMISSION
RATES. We estimated hospital-speciﬁc 30-day RSRRs
using a hierarchical mixed-effects logistic regression
model adjusted for demographics and comorbidities.
To account for within-hospital correlation, we esti-
mated a random intercept for each hospital by
including the hospital variable as a random effect
variable. We estimated the hospital-speciﬁc RSRR by
calculating the ratio of the predicted 30-day read-
mission rate within each hospital to the expected
30-day readmission rate within each hospital. WeTABLE 1 Baseline Characteristics of the Study Sample
Variable
Total Cohort
(N ¼ 180,059 Procedures)
Age, yrs 76.3  6.4
Age >80 yrs 29.4
Male 56.4
Caucasian 93.2
Comorbidities
Symptomatic carotid stenosis 9.7
Diabetes 43.3
Diabetes with peripheral complications 6.9
Hypertension 89.3
Hypertensive complications 14.0
Congestive heart failure 19.7
Coronary atherosclerosis 63.4
Acute coronary syndrome 8.5
Precerebral arterial occlusion 86.6
Cerebral atherosclerosis 10.7
Unspeciﬁed cerebrovascular disease 3.8
Vascular disease 43.1
Vascular disease with complications 5.7
Renal failure 17.6
End-stage renal disease 1.0
Values are mean  SD or %. *Student t test (for continuous variables) or chi-square tes
CAS ¼ carotid artery stenting; CEA ¼ carotid endarterectomy.used this ratio to standardize an unadjusted national
(U.S.) average of readmission rates following carotid
revascularization procedures. We estimated the pre-
dicted readmission rate of each hospital using the
random intercept speciﬁc to that hospital and the
population mix within that hospital. We calculated
the hospital expected readmission rate from a mean
hospital intercept, calculated from our sample of
hospitals and the population mix of that speciﬁc
hospital.
We also examined differences in hospital-speciﬁc
RSRRs by the utilization of a carotid revasculariza-
tion strategy. In order to obtain a stable estimate of
hospitals’ proportional use of CAS, we limited this
analysis to data from hospitals that performed at least
25 carotid revascularization procedures during the
observation period. To examine whether hospital
RSRR varied by the proportion of revascularization
procedures performed using CAS, we stratiﬁed hos-
pitals into 5 groups by their proportional use of
CAS among all carotid revascularization procedures
(0%, >0% to 10%, >10% to 20%, >20% to 30%, and
>30%). We utilized descriptive statistics to summa-
rize hospital-speciﬁc RSRRs within each hospital
group. We then compared the medians of these 5
hospital groups using a Kruskal-Wallis test. The studyStudy Groups
CAS
(n ¼ 33,228 Procedures)
CEA
(n ¼ 146,831 Procedures) p Value*
76.1  6.6 76.3  6.3 <0.001
29.1 29.5 0.139
53.2 57.1 <0.001
90.2 93.9 <0.001
13.7 8.8 <0.001
40.9 43.9 <0.001
6.8 6.9 0.322
85.7 90.1 <0.001
15.2 13.7 <0.001
23.9 18.7 <0.001
62.3 63.6 <0.001
10.2 8.1 <0.001
71.5 90.0 <0.001
19.1 8.8 <0.001
3.8 3.8 0.813
45.2 42.6 <0.001
6.3 5.6 <0.001
19.0 17.3 <0.001
1.2 1.0 <0.001
t (for categorical variables).
FIGURE 1 Readmissions at 30 Days After the End of Hospitalizations for Carotid Revascularization Procedures
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Patients undergoing carotid revascularization were disproportionately at risk for readmission in the ﬁrst week after the end of hospitalization,
with 44.3% of all admissions occurring within 1 week of discharge. However, they remained at risk for readmission throughout the 30-day
period.
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1401protocol was approved by the Human Investigation
Committee of Yale University School of Medicine. We
used SAS version 9.3 (SAS Institute, Cary, North
Carolina) for statistical analyses and deﬁned statis-
tical signiﬁcance as 2-tailed p < 0.05.FIGURE 2 Most Common Principal Discharge Diagnoses Associated
Complications of Care
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Heart Failure
Pneumonia Including Aspiration Pneumonitis
Acute Stroke
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Other Peripheral Vascular Disease
Precerebral Arterial Occlusion/Transient
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Renal Disorders Including Renal Failure
Hemorrhage
Patients were readmitted with a wide range of diagnoses, with no single
cerebral complications including ischemic stroke, transient ischemic atta
of readmissions.RESULTS
We identiﬁed 168,323 patients who underwent a
total of 180,059 carotid revascularization procedures
(93.2% patients underwent 1 carotid intervention;With Readmissions Following Carotid Interventions
8.6
6.6
4 6 8 10
30-Day Readmissions, %
diagnosis contributing to more than 10% of readmissions. However,
ck, and cerebral hemorrhage were collectively responsible for 10.7%
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14026.8% underwent >1 carotid intervention) at 2,287
hospitals between January 1, 2009 and December 31,
2011. Of these 180,059 procedures, 81.5% (146,831)
were CEA and 18.5% (33,228) were CAS. The mean
age of the cohort was 76.3 years, and 93.2% of
included patients were Caucasian (Table 1). Symp-
tomatic carotid stenosis, diabetes, hypertension,
and congestive heart failure were present in 9.7%,
43.3%, 89.3%, and 19.7% of the study population,
respectively. A total of 43.1% of patients had other
peripheral vascular diseases, and 17.6% had renal
failure.
The unadjusted 30-day readmission rate following
carotid revascularization was 9.6% (17,202 pro-
cedures). One-fourth of all readmissions occurred
within 3 days of hospital discharge, 44.3% occurred
within the ﬁrst 7 days of discharge, and 67.8%
occurred within the ﬁrst 14 days of discharge
(Figure 1). The unadjusted 30-day mortality rate
following carotid revascularization was 1.2% (2,247
procedures). The reasons for readmission followingFIGURE 3 Distribution of the Most Common Diagnoses Associated W
Complications of Care
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Some readmission diagnoses varied over time. For instance, complication
during the ﬁrst week following hospitalization. In contrast, other periphe
more common in the third and fourth week following hospitalization.carotid revascularization procedures were broad
(Figure 2), with the 10 most common readmission
diagnoses contributing only 50.0% of all 30-day
readmissions. The most common reasons for read-
mission were complications of care (8.6%), heart
failure (6.6%), and pneumonia (including aspiration
pneumonitis) (5.2%). Themost common complications
of care included hematoma formation (2.3%), iatro-
genic stroke/intracranial hemorrhage (0.8%), and
non–central nervous system bleeding (0.5%). Addi-
tionally, cerebral complications including ischemic
stroke, transient ischemic attack, and cerebral hem-
orrhage were collectively associated with 10.7% of
readmissions. Some readmission diagnoses varied
over time (Figure 3). For instance, complications of
care, heart failure, and acute stroke were more
often encountered during the ﬁrst week following
discharge. In contrast, other peripheral vascular dis-
eases, chronic angina, and coronary artery disease
were more common in the third and fourth weeks
following discharge.ith Readmission at 30 Days Over Days 0 to 7, 8 to 15, and 16 to 30
0–7 Days
8–15 Days
16–30 Days
30-Day Readmissions, %
6 8 10 12 14
13.0
s of care, heart failure, and acute stroke were more often encountered
ral vascular diseases, chronic angina and coronary artery disease were
CENTRAL ILLUSTRATION Readmissions After Carotid Artery Revascularization in the Medicare Population
The risk for readmission was signiﬁcantly greater among patients undergoing carotid artery stenting (CAS) compared with patients undergoing
carotid endarterectomy (CEA) (top: CAS, blue line; CEA, salmon line). However, the risk-standardized readmission rates (RSRRs) of hospitals
that used CAS more frequently were comparable to those of hospitals that performed CAS less frequently (bottom).
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1404PROCEDURE-SPECIFIC READMISSION RATE: CAS
VERSUS CEA. The characteristics of patients under-
going CEA and CAS procedures varied modestly
(Table 1). The mean ages of CAS and CEA patients
were 76.1 and 76.3 years, respectively. Male patients
and Caucasian patients were more likely to have
undergone CEA than CAS. Greater proportions of
patients undergoing CEA had diabetes, hypertension,
and coronary atherosclerosis (all, p < 0.001). In
contrast, greater proportions of CAS patients had
symptomatic carotid stenosis, congestive heart fail-
ure, coronary syndrome, other peripheral vascular
diseases, and chronic renal failure (all, p < 0.001).
Crude 30-day readmission rates following CEA
and CAS were 9.0% (13,222 of 146,831) and 12.0%
(3,980 of 33,228), respectively. On multivariate anal-
ysis, the adjusted risk for readmission was signi-
ﬁcantly greater among patients undergoing CAS
compared with that in patients undergoing CEA
(adjusted odds ratio [AOR]: 1.13; 95% conﬁdence in-
terval [CI]: 1.08 to 1.18; p < 0.001) (Central Illustration,
upper panel). Within the propensity-matched sub-
group, CAS patients also had a signiﬁcantly greater
rate of readmission compared with that in patients
undergoing CEA (AOR: 1.18; 95% CI: 1.07 to 1.23;
p < 0.001).
Symptomatic patients were signiﬁcantly more
likely to have been readmitted compared with asymp-
tomatic patients (AOR: 1.18; 95% CI: 1.12 to 1.24;
p < 0.001) (Figure 4). Other notable predictors of
readmissions were age >65 years (AOR: 1.01; 95% CI:
1.01 to 1.02; p < 0.001), female sex (AOR: 1.12; 95%
CI: 1.08 to 1.15; p < 0.001), and non-Caucasian race
(AOR: 1.12; 95% CI: 1.06 to 1.19; p< 0.001).
In stratiﬁed analyses, compared with CEA, CAS was
associated with greater rates of readmission in both
patients with symptomatic (AOR: 1.24; 95% CI: 1.12 to
1.37; p < 0.001) and asymptomatic (AOR: 1.10; 95% CI:
1.05 to 1.14; p < 0.001) carotid stenosis. An interaction
term (symptomatic status  procedural approach)
was not signiﬁcant. Similarly, compared with CEA,
CAS was associated with greater rates of readmission
among patients age >80 years (AOR: 1.12; 95% CI: 1.04
to 1.20; p < 0.001), patients age <80 years (AOR: 1.12;
95% CI: 1.07 to 1.18; p < 0.001), male patients (AOR:
1.13; 95% CI: 1.07 to 1.19; p < 0.001), female patients
(AOR: 1.13; 95% CI: 1.07 to 1.20; p < 0.001), Caucasian
race (AOR: 1.11; 95% CI: 1.06 to 1.16; p < 0.001) and
non-Caucasian race (AOR: 1.25; 95% CI: 1.10 to 1.42;
p < 0.001).
HOSPITAL-SPECIFIC RISK-STANDARDIZED READMISSION
RATES. There was modest hospital-level variation
in 30-day RSRRs (Figure 5). The median hospital30-day RSRR was 9.5%, with a range of 7.5% to 12.5%
and an interquartile range of 9.2% to 10.0%. The use
of CAS varied signiﬁcantly across hospitals (Figure 6).
Of the 2,287 hospitals, 1,500 (65.6%) performed more
than 25 carotid revascularization procedures and
were included in our analysis of hospitals’ propor-
tional use of CAS. Variation in the proportional use of
CAS was not associated with signiﬁcant differences in
hospital RSRR (p ¼ 0.771) (Central Illustration, lower
panel).
DISCUSSION
Among Medicare patients undergoing carotid revas-
cularization, 9.6% were readmitted within 30 days of
discharge (2,6–9). A high proportion of readmissions
occurred within the ﬁrst 7 days of hospital discharge,
and readmissions were associated with a wide range
of principal diagnoses. Furthermore, we observed
that patients undergoing CAS were at greater risk for
readmission compared with patients undergoing CEA.
Yet hospitals performing a greater proportion of
revascularization via CAS did not have greater hos-
pital 30-day RSRRs.
CMS has indicated its intent to publicly report
hospitals’ 30-day readmission rates in patients
undergoing vascular procedures, which includes
carotid revascularization procedures (3). A measure
of vascular readmissions has been submitted to the
National Quality Forum for evaluation, and in the
future, hospitals with greater-than-expected read-
mission rates may be subject to payment penalties
(3,10). In this context, our analyses of hospital
RSRRs have important implications. We have char-
acterized both current national performance and
the extent of hospital variation in readmissions
following carotid revascularization. This informa-
tion provides a benchmark to which hospitals can
evaluate efforts to reduce readmission rates in this
population.
We found that although patients undergoing
carotid revascularization were at a disproportionately
higher risk for readmission in the ﬁrst week after
discharge, they remained at substantial risk for
readmission throughout the 30-day post-discharge
period. Furthermore, patients were readmitted with a
wide range of diagnoses, including cardiovascular,
pulmonary, neurological, and renal disorders, as well
as complications of care, with no single diagnosis
contributing tomore than 10% of readmissions. Indeed,
the 10 most common readmission diagnoses were
collectively involved in only one-half of readmissions.
Yet, almost one-third of readmission diagnoses were
potentially due to procedural complications, including
FIGURE 4 Forest Plot of Odds Ratios for Risk Factors Associated With Readmission at 30 Days
Odds Ratio and 95% CI of GEE model
Age > 65, Continuous
Female
CAS (reference: CEA)
Caucasian race (reference: Non-Caucasian)
Symptomatic Carotid Stenosis
Diabetes or DM complications
Diabetes with Neurologic/Peripheral Circulatory Manifestation
Precerebral Arterial Occlusion and Transient Cerebral Ischemia
Cerebral Atherosclerosis and Aneurysm
Cerebrovascular Disease, Unspecified
Cerebrovascular Disease Late Effects, Unspecified
Vascular Disease with Complications
Vascular Disease
History of infection
Metastatic cancer or acute leukemia
Cancer
Benign neoplasms of skin, breast and eye
Protein-calorie malnutrition
Disorders of fluid, electrolyte, acid-base
Other Endocrine/Metabolic/Nutritional Disorders
Pancreatic Disease
Peptic Ulcer, Hemorrhage, Other Gastrointestinal Disorders
Severe hematological disorders'
Dementia or other specified brain disorders
Hemiplegia, paraplegia, paralysis, functional disability
Congestive heart failure
Acute coronary syndrome
Coronary atherosclerosis or angina
Hypertensive Heart and Renal Disease or Encephalopathy
Hypertensive heart disease
Hypertension
Specified arrhythmias
Ischemic or Unspecified Stroke
COPD
Pneumonia
Other Lung Disorders
End stage renal disease or dialysis
Renal failure
Chronic Ulcer of Skin, Except Decubitus
Cellulitis, local skin infection
Other injuries
0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80
1.01
1.12
1.12
1.18
1.06
1.15
0.94
1.03
1.07
1.18
1.11
1.08
1.06
1.38
0.95
1.27
1.14
0.77
1.00
1.08
1.16
1.19
1.14
1.22
1.11
1.16
1.20
0.97
0.84
1.14
1.11
1.24
1.10
1.25
1.39
1.11
1.10
1.07
1.13
0.89
0.54
A wide range of demographic characteristics and baseline comorbidities were associated with an increased risk for readmission, most notably,
age, female sex, non-Caucasian race, symptomatic carotid stenosis, diabetes, congestive heart failure, acute coronary syndrome, and ischemic
stroke.
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1405cerebral events (10.7%), complications of care (8.6%),
acute coronary syndrome (5.0%), and arrhythmias
(4.0%). These complications may represent high-yield
areas for targeted efforts to reduce readmission.
However, the broad range of diagnoses is consistent
with the theory that patients experience a period of
increased risk for a variety of illnesses following hos-
pital discharge (11,12). As such, interventions targeting
a speciﬁc readmission diagnosis or time period may be
relatively ineffective in reducing readmission rates.
Instead, more general strategies leading to improve-
ment in discharge planning, medication reconcilia-
tion, and early follow-up after discharge may betteraddress underlying vulnerabilities in the transitional
care process (13).
In our sample of Medicare patients, the rates of
readmission attributed to stroke and myocardial
infarction were 0.5% (883 of 180,059) and 0.5% (861 of
180,059), respectively. These rates are less than the
rates of similar events reported by comparable ran-
domized controlled trials (stroke: CREST [Carotid
Revascularization Endarterectomy versus Stenting
Trial] (1) 3.2%, SAPPHIRE [Stenting and Angioplasty
With Protection in Patients at High Risk for Endar-
terectomy] (14) 3.3%; myocardial infarction: CREST
1.7%, SAPPHIRE 4.2%). However, direct comparisons
FIGURE 5 Distribution of Hospital-Speciﬁc RSRRs at 30 Days After
Carotid Revascularization Procedures
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There was modest hospital-level variation in 30-day risk-standardized readmission rates
(RSRRs) (median: 9.5%; interquartile range: 9.2% to 10.0%).
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1406are challenging given that the present study included
only events that occurred after hospital discharge,
whereas the numbers reported in the clinical trials
included events that occurred during both hospitali-
zation and follow-up. Our results suggest that the
majority of these complications occur during hospi-
talization and are relatively rare following discharge.
Consistent with prior investigators, we found that
CAS patients were more likely to have been read-
mitted than were CEA patients (2). The difference intion of Hospital Proportional CAS Use
15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95100
Hospital CAS Percentage (%)
e hospitals did not perform a carotid artery stenting (CAS) procedure,
that performed both carotid endarterectomy (CEA) and CAS, the
AS varied widely.the risk for readmission is likely driven in part by
patient selection. Currently, CEA is the mainstay
treatment of symptomatic and asymptomatic carotid
artery stenosis, and CAS is typically reserved for pa-
tients with comorbidities or anatomy that put them at
increased risk for adverse outcomes following CEA
(1,15,16). Nonetheless, the risk for readmission with
CAS was greater than that with CEA even after
observed differences in patient characteristics were
accounted for. This ﬁnding may reﬂect the limitations
of administrative data, but additional research
examining whether the excess risk could be mitigated
is warranted. CAS is still a relatively new procedure,
and the excess risk for readmission may reﬂect the
learning curve associated with incorporating CAS into
routine clinical practice. Within a hospital, CAS may
be performed by physicians in different specialties
with a range of experience and expertise, and re-
searchers have shown that most physicians who
perform CAS are low-volume operators with variable
use of recommended strategies, such as the use of
embolic protection (17,18). Therefore, there may be an
opportunity for improving care by consolidating
experience within a smaller team. Such an approach
could have ancillary beneﬁts with regard to reducing
readmissions by facilitating a smooth transition of
care from the inpatient to the outpatient setting.
In our study, we identiﬁed a wide range of
demographic characteristics (e.g., advancing age,
female sex, and non-Caucasian race) and baseline
comorbidities (e.g., symptomatic carotid stenosis,
diabetes, congestive heart failure, acute coronary
syndrome, and ischemic stroke) associated with an
increased risk for readmission. These factors may
serve as important markers for identifying patients at
risk for readmission.
In our sample of hospitals, a large proportion of the
hospitals did not perform a CAS procedure, and
among hospitals that performed both CEA and CAS,
the proportional use of CAS varied widely. Of all
hospitals that performed carotid revascularization
procedures, only 135 (9%) performed more CAS than
CEA. Importantly, although readmissions were more
common after CAS than after CEA, the RSRRs of
hospitals that used CAS more frequently were com-
parable to those of hospitals that performed CAS less
frequently. This observation suggests that hospitals
using CAS more frequently will not necessarily be
disadvantaged if and when measures of vascular
readmissions are publicly reported and included in
payment programs.
STUDY LIMITATIONS. First, we used administrative
claims data to identify the sample population and
associated comorbidities. Such databases are subject
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Almost 10% of
Medicare patients undergoing carotid revascularization are
readmitted to the hospital within 30 days of discharge for a wide
range of conditions, most of which occur within 7 days after
discharge. Carotid artery stenting is associated with 30-day
readmission rates greater than that with endarterectomy.
TRANSLATIONAL OUTLOOK: Further investigation is
warranted for developing strategies that reduce the need
for hospital readmission following carotid revascularization
procedures.
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1407to coding errors, coding differences across providers
and institutions, and changes in coding patterns over
time (19,20). The accuracy of these coding systems in
identifying carotid revascularization has not been
reported; however, the speciﬁcity and positive pre-
dictive values in identifying comorbidities in cardio-
vascular patients are generally reasonable (21,22).
Second, administrative claims data may not be suit-
able for identifying staged revascularization pro-
cedures, as some physicians may elect to perform the
carotid repair over 2 or more consecutive sessions.
These planned readmissions were included in our
model despite being unrelated to the provided care
quality and, consequently, may have inﬂated our
readmission estimates. Third, administrative claims
data do not provide detailed information about the
procedure itself (11,23). Other sources of data such as
clinical registries may provide insight into the asso-
ciation of intraprocedural practices and the risk for
subsequent readmission. Finally, the patients in our
cohort were not randomized to the carotid revascu-
larization strategies, and as a result, residual con-
founds may be present in our observed association
despite the use of propensity score matching.
CONCLUSIONS
One in 10 Medicare patients undergoing carotid
revascularization is readmitted within 30 days. Thepresent study is in large part foundational, raising
awareness among clinicians, hospital administrators,
and policymakers regarding this issue and illustrating
the extent to which readmission rates differ by the
type of revascularization procedure.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Jeptha P. Curtis, Cardiovascular Division, Department
of Medicine, Yale University School of Medicine, P.O.
Box 208056, 333 Cedar Street, New Haven, Con-
necticut 06520-8056. E-mail: jeptha.curtis@yale.edu.RE F E RENCE S1. Brott TG, Hobson RW 2nd, Howard G, et al., for
the CREST Investigators. Stenting versus endar-
terectomy for treatment of carotid-artery steno-
sis. N Engl J Med 2010;363:11–23.
2. Galiñanes EL, Dombroviskiy VY, Hupp CS,
Kruse RL, Vogel TR. Evaluation of readmission
rates for carotid endarterectomy versus carotid
artery stenting in the US Medicare population.
Vasc Endovascular Surg 2014;48:217–23.
3. Bernheim SG, Li L, Li S-X, et al. Hospital
30-day all-cause risk-standardized readmission
rate (RSRR) following vascular procedures—
Measure Methodology report. 2011.
4. Brinjikji W, El-Sayed AM, Kallmes DF, Lanzino G,
Cloft HJ. Racial and insurance based disparities in
the treatment of carotid artery stenosis: a study of
the Nationwide Inpatient Sample. J Neurointerv
Surg 2014 Jul 11 [E-pub ahead of print].
5. Giacovelli JK, Egorova N, Dayal R, Gelijns A,
McKinsey J, Kent KC. Outcomes of carotid stenting
compared with endarterectomy are equivalent in
asymptomatic patients and inferior in symptomatic
patients. J Vasc Surg 2010;52:906–13.e1–4.
6. Curran T, Lo RC, Fokkema M, et al. Predictors of
30-day readmission and postdischarge mortality
following carotid endarterectomy in the ACS-
NSQIP. J Vasc Surg 2013;57:93–4S.7. Gupta PK, Fernandes-Taylor S, Ramanan B,
Engelbert TL, Kent KC. Unplanned readmissions
after vascular surgery. J Vasc Surg 2014;59:473–82.
8. Kennedy BS, Fortmann SP, Stafford RS. Elective
and isolated carotid endarterectomy: health dis-
parities in utilization and outcomes, but not
readmission. J Natl Med Assoc 2007;99:480–8.
9. Rambachan A, Smith TR, Saha S, Eskandari MK,
Bendok BR, Kim JY. Reasons for readmission after
carotid endarterectomy. World Neurosurg 2014;
82:e771–6.
10. Medicare Payment Advisory Committee.
Report to the Congress: Promoting Greater
Efﬁciency in Medicare. 2007. Available at:
http://www.medpac.gov/documents/reports/Jun07_
EntireReport.pdf. Accessed March 2, 2015.
11. Dharmarajan K, Hsieh AF, Lin Z, et al.
Diagnoses and timing of 30-day readmissions after
hospitalization for heart failure, acute myocardial
infarction, or pneumonia. JAMA 2013;309:355–63.
12. Krumholz HM. Post-hospital syndrome—an
acquired, transient condition of generalized risk.
N Engl J Med 2013;368:100–2.
13. Brooke BS, De Martino RR, Girotti M,
Dimick JB, Goodney PP. Developing strategies for
predicting and preventing readmissions in vascular
surgery. J Vasc Surg 2012;56:556–62.14. Yadav JS, Wholey MH, Kuntz RE, et al. Pro-
tected carotid-artery stenting versus endarterec-
tomy in high-risk patients. N Engl J Med 2004;
351:1493–501.
15. Al-Damluji MS, Nagpal S, Stilp E, Remetz M,
Mena C. Carotid revascularization: a systematic
review of the evidence. J Interv Cardiol 2013;26:
399–410.
16. Brott TG, Halperin JL, Abbara S, et al. 2011
ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/
SCAI/SIR/SNIS/SVM/SVS guideline on the manage-
ment of patients with extracranial carotid and
vertebral artery disease: executive summary: a
report of the American College of Cardiology
Foundation/American Heart Association Task Force
on Practice Guidelines, and the American Stroke
Association, American Association of Neuroscience
Nurses, American Association of Neurological Sur-
geons, American College of Radiology, American
Society of Neuroradiology, Congress of Neurological
Surgeons, Society of Atherosclerosis Imaging and
Prevention, Society for Cardiovascular Angiography
and Interventions, Society of Interventional Radi-
ology, Society of NeuroInterventional Surgery, Soci-
ety for Vascular Medicine, and Society for Vascular
Surgery. J Am Coll Cardiol 2011;57:e16–94.
17. Nallamothu BK, Gurm HS, Ting HH, et al.
Operator experience and carotid stenting
Al-Damluji et al. J A C C V O L . 6 5 , N O . 1 4 , 2 0 1 5
Readmissions After Carotid Artery Revascularization A P R I L 1 4 , 2 0 1 5 : 1 3 9 8 – 4 0 8
1408outcomes in Medicare beneﬁciaries. JAMA 2011;
306:1338–43.
18. Perler BA, Dardik A, Burleyson GP, Gordon TA,
Williams GM. Inﬂuence of age and hospital
volume on the results of carotid endarterectomy:
a statewide analysis of 9918 cases. J Vasc Surg
1998;27:25–31, discussion 31–3.
19. Eslami MH, McPhee JT, Simons JP, Schanzer A,
Messina LM. National trends in utilization and post-
procedure outcomes for carotid artery revasculari-
zation 2005 to 2007. J Vasc Surg 2011;53:307–15.
20. Iezzoni LI, Foley SM, Daley J, Hughes J,
Fisher ES, Heeren T. Comorbidities, complications,and coding bias. Does the number of diagnosis
codes matter in predicting in-hospital mortality?
JAMA 1992;267:2197–203.
21. Birman-Deych E, Waterman AD, Yan Y,
Nilasena DS, Radford MJ, Gage BF. Accuracy of
ICD-9-CM codes for identifying cardiovascular and
stroke risk factors. Med Care 2005;43:480–5.
22. Kiyota Y, Schneeweiss S, Glynn RJ,
Cannuscio CC, Avorn J, Solomon DH. Accuracy of
Medicare claims-based diagnosis of acute myocar-
dial infarction: estimating positive predictive value
on the basis of review of hospital records. Am Heart
J 2004;148:99–104.23. Calvillo-King L, Arnold D, Eubank KJ, Lo M,
Yunyongying P, Stieglitz H, Halm EA. Impact of
social factors on risk of readmission or mortality in
pneumonia and heart failure: systematic review.
J Gen Intern Med 2013;28:269–82.
KEY WORDS carotid artery stenosis,
carotid artery stenting, carotid
endarterectomy, hospital readmission
APPENDIX For supplemental tables, please
see the online version of this article.
